IGC Pharma
26 hedge funds and large institutions have $1M invested in IGC Pharma in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% less capital invested
Capital invested by funds: $1.46M → $1M (-$461K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
26
Holding in Top 10
–
Calls
–
Puts
$3K
Top Buyers
| 1 | +$62K | |
| 2 | +$23K | |
| 3 | +$17.2K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$15.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.18K |
Top Sellers
| 1 | -$30.2K | |
| 2 | -$16.8K | |
| 3 | -$3.74K | |
| 4 |
Morgan Stanley
New York
|
-$61 |
| 5 |
Goldman Sachs
New York
|
-$1 |